What is Bristol-Myers Squibb's proceeds from other short-term debt?

Bristol-Myers Squibb (BMY) reported proceeds from other short-term debt of $321.00M in Q1 2026.

How has Bristol-Myers Squibb's proceeds from other short-term debt changed year-over-year?

Bristol-Myers Squibb's proceeds from other short-term debt decreased by 12.8% year-over-year, from $368.00M to $321.00M.

What does proceeds from other short-term debt mean?

Cash received from short-term loans or credit facilities outside of standard commercial paper markets.

Financing

Proceeds from other short-term debt

Bristol-Myers Squibb Proceeds from other short-term debt increased by 6320.0% to $321.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.8%, from $368.00M to $321.00M.

Analysis

StatementCash Flow Statement

SectionFinancing

CategoryLiquidity

SignalContext dependent

VolatilityModerate

First reportedQ1 2022

Last reportedQ1 2026Apr 30, 2026

How to read this metric

Increased reliance on these proceeds may suggest tightening liquidity or a need for bridge financing, while minimal use indicates strong internal cash generation.

Detailed definition

This captures cash inflows from short-term borrowing arrangements other than commercial paper, such as bank lines of cre...

Peer comparison

Commonly used by large corporations as a backup liquidity source or for specific short-term funding requirements.

Metric ID: financing_proceeds_from_other_short_term_debt

Historical Data

12 periods

	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q1 '25	Q2 '25	Q3 '25	Q1 '26
Value	$48.50M	$48.50M	$48.50M	$48.50M	-$353.00M	$83.00M	$326.00M	$95.00M	$368.00M	$58.00M	$5.00M	$321.00M
QoQ Change	—	+0.0%	+0.0%	+0.0%	-827.8%	+123.5%	+292.8%	-70.9%	+287.4%	-84.2%	-91.4%	>999%
YoY Change	—	—	—	—	-827.8%	—	—	—	+343.4%	-82.2%	-94.7%	-12.8%

Range-$353.00M – $368.00M

CAGR+98.8%

Avg YoY Growth-134.8%

Median YoY Growth-82.2%

Proceeds from other short-term debt at Other Companies

Duke EnergyDUK View metric

Raytheon TechnologiesRTX View metric

Dominion EnergyD View metric

Keurig Dr PepperKDP View metric

General Purpose Acquisition Corp. GPAC View metric

PrologisPLD View metric

Frequently Asked Questions

What is Bristol-Myers Squibb's proceeds from other short-term debt?: Bristol-Myers Squibb (BMY) reported proceeds from other short-term debt of $321.00M in Q1 2026.
How has Bristol-Myers Squibb's proceeds from other short-term debt changed year-over-year?: Bristol-Myers Squibb's proceeds from other short-term debt decreased by 12.8% year-over-year, from $368.00M to $321.00M.
What does proceeds from other short-term debt mean?: Cash received from short-term loans or credit facilities outside of standard commercial paper markets.